Home ⟩ Insights

Insights

long-ideas

3 min read • January 3, 2022

Whitney Tilson Names Cannabis ETF ‘Favorite Pick For 2022’ But Clock Is Ticking To Change US Regulations

2 min read • October 13, 2021

Why MSO Uplistings Could Be The Next Major Cannabis Stock Catalyst

2 min read • October 7, 2021

Tilray Stock Breaks Below Pattern: What’s Next For The Cannabis Stock?

2 min read • September 10, 2021

Where Tilray Might Go In Coming Weeks As Cannabis Stock Nears End Of Pattern

1 min read • August 4, 2021

Is It Time To Buy The Alternative Harvest Cannabis ETF MJ?

2 min read • July 14, 2021

What’s Next As Aurora Cannabis Is Nearing The Breakout Point Of A Pennant Pattern

3 min read • May 17, 2021

US Cannabis Legislation Update: ‘SAFE Act Gaining Steam’

6 min read • April 19, 2021

Is This The Most Undervalued And Highest Growth ASX-Listed Cannabis Stock?

2 min read • March 30, 2021

3 Cannabis Stocks Looking For Support

3 min read • February 10, 2021

5 Reasons Why C21 Investments Is Ready To Take On The Big Cannabis MSOs

3 min read • December 16, 2020

Aphria-Tilray Marriage Could Mean 420 In December For This Cannabis ETF

4 min read • December 14, 2020

3 Cannabis SPACs To Consider For 2021

Latest Headlines

4 min read • August 31, 2026

Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 2

5 min read • August 31, 2026

Glass House, America’s Largest Cannabis Grower by Canopy, Rings the NYSE Bell

6 min read • August 31, 2026

USCR Urges Congress to Keep the Hemp Loophole Closed

4 min read • August 28, 2026

Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 1

3 min read • August 28, 2026

$10 Million in Taxpayer Money Was Diverted Into Florida’s Fight Against Marijuana Legalization, Grand Jury Says

2 min read • August 28, 2026

PharmaCielo Revenue Surges 330%; European Cannabis Flower Sales Take Off

5 min read • August 27, 2026

Massachusetts Could Kill Its $1.6 Billion Cannabis Market and Close 300+ Stores, CEO Warns

2 min read • August 27, 2026

IM Cannabis Implements 30-for-1 Reverse Stock Split as It Fights to Maintain Nasdaq Listing

4 min read • August 26, 2026

Four Things Nobody Told You About the DEA Cannabis Hearings — But You Probably Wanted to Ask

3 min read • August 26, 2026

Financial Times: Germany’s Cannabis Imports Surge Sixfold, Regulatory Pressure Mounts

3 min read • August 25, 2026

Comply With What? Hemp Ban Nears; the FDA Leaves Industry Waiting for Answers

4 min read • August 25, 2026

Curaleaf vs. Aurora: The $4 Cannabis Takeover Fight Gets Hostile — Literally

Browse By Channels

After-Hours Center

Analyst Ratings

Be Your Own Boss

Broad U.S. Equity ETFs

california cannabis

cannabis cultivation

cannabis earnings

Christopher Dillis

Congress cannabis

Earnings Misses

Emerging Market ETFs

Emerging Markets

Entrepreneurship

Federal Reserve

Financial Advisors

first quarter earnings

germany cannabis

hemp legalization

hemp regulation

IgniteIt Events

illegal cannabis farms

intoxicating hemp-derived products

Intraday Update

Macro Economic Events

Macro Notification

Market-Moving Exclusives

Movers & Shakers

Personal Finance

Pre-Market Outlook

Small Cap Analysis

Success Stories

UC Berkeley Cannabis Research Center

unlicensed cannabis

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.